New human tracer data show that the same dietary fatty-acid exposure can produce very different biological outcomes depending on metabolic state. For the endocannabinoid system, this strengthens the case for measuring achieved DBS/RBC fatty-acid profiles rather than assuming intake equals substrate availability.
